TrialBMC cancer2015

Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in Japan.

Masatoshi Eto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.